Groowe Groowe / Newsroom / KAPA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KAPA News

Kairos Pharma, Ltd.

Kairos Pharma, Ltd. gibt Unterzeichnung einer Grundsatzvereinbarung über den strategischen Erwerb von zwei klinischen Onkologie-Assets von Celyn Therapeutics bekannt

businesswire.com
KAPA

Kairos Pharma, Ltd. annonce la signature d'une feuille de modalités visant l'acquisition stratégique de deux actifs en oncologie clinique de Celyn Therapeutics

businesswire.com
KAPA

Form 8-K

sec.gov
KAPA

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

businesswire.com
KAPA

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

accessnewswire.com
COE ACCS ASNS DRTS AREB BKYI FUFU CJMB DVLT FBLG MEHA HCTI INDO JUNS KAPA LIXT MYSZ NNVC HOVR NOMA OPTT OWLS PERF PHIO PROP PRPO SJ LITM SOPA SNGX XHLD TYGO TIVC TRX WGRX WWR ZENA FLGC

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

accessnewswire.com
COE ACCS ASNS DRTS AREB BKYI FUFU CJMB DVLT FBLG MEHA HCTI INDO JUNS KAPA LIXT MYSZ NNVC HOVR NOMA OPTT OWLS PERF PHIO PROP PRPO SJ LITM SOPA SNGX XHLD TYGO TIVC TRX WGRX WWR ZENA FLGC

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

accessnewswire.com
COE ACCS ASNS DRTS AREB BKYI FUFU CJMB DVLT FBLG MEHA HCTI INDO JUNS KAPA LIXT MYSZ NNVC HOVR NOMA OPTT OWLS PERF PHIO PROP PRPO SJ LITM SOPA SNGX XHLD TYGO TIVC TRX WGRX WWR ZENA FLGC

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

accessnewswire.com
COE ACCS ASNS DRTS AREB BKYI FUFU CJMB DVLT FBLG MEHA HCTI INDO JUNS KAPA LIXT MYSZ NNVC HOVR NOMA OPTT OWLS PERF PHIO PROP PRPO SJ LITM SOPA SNGX XHLD TYGO TIVC TRX WGRX WWR ZENA FLGC

Kairos Pharma to Present at 3 rd Annual DealFlow Discovery Conference

businesswire.com
KAPA

Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer

businesswire.com
KAPA